World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03031054
Date of registration: 21/01/2017
Prospective Registration: Yes
Primary sponsor: Tri-Service General Hospital
Public title: The Effect of Hyaluronic Acid for Carpal Tunnel Syndrome
Scientific title: The Effect of Hyaluronic Acid in Patients With Carpal Tunnel Syndrome
Date of first enrolment: March 1, 2017
Target sample size: 35
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03031054
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Name:     Yung-Tsan Wu, MD
Address: 
Telephone:
Email:
Affiliation:  Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age between 20-80 year-old.

- Diagnosis was confirmed using an electrophysiological study

Exclusion Criteria:

- Cancer

- Coagulopathy

- Pregnancy

- Inflammation status

- Cervical radiculopathy

- Polyneuropathy, brachial plexopathy

- Thoracic outlet syndrome

- Previously undergone wrist surgery or steroid injection for CTS



Age minimum: 20 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Carpal Tunnel Syndrome
Intervention(s)
Procedure: Sono-guided injection with hyaluronic acid
Procedure: Sono-guided injection with normal saline
Primary Outcome(s)
Change from baseline of severity of symptoms and functional status on 2nd week, 1st, 3rd, 6th month and one year after injection [Time Frame: Pre-treatment, 2nd week, 1st, 3rd, 6th month and one year]
Secondary Outcome(s)
Change from baseline of cross-sectional area of the median nerve on 2nd week, 1st, 3rd, 6th month and one year after injection [Time Frame: Pre-treatment, 2nd week, 1st, 3rd, 6th month and one year]
Change from baseline of conduction velocity, amplitude of median nerve on 2nd week, 1st, 3rd, 6th month and one year after injection [Time Frame: Pre-treatment, 2nd week, 1st, 3rd, 6th month and one year]
Change from baseline of finger pinch on 2nd week, 1st, 3rd, 6th month and one year after injection [Time Frame: Pre-treatment, 2nd week, 1st, 3rd, 6th month and one year]
Change from baseline of pain on 2nd week, 1st, 3rd, 6th month and one year after injection [Time Frame: Pre-treatment, 2nd week, 1st, 3rd, 6th month and one year]
Secondary ID(s)
HA for CTS
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history